✨ Medicine Classification Schedules




1 MARCH

NEW ZEALAND GAZETTE

Schedule 2

Restricted Medicines

Aminophylline; in liquid form for oral use in medicines containing 2% or less

Atropine; in liquid form for oral use; in solid dose form containing more than 0.3 milligrams per dose or more than 1 milligram per recommended daily dose; except in medicines containing 100 micrograms or less per litre or per kilogram

Glucagon; except in medicines containing 100 micrograms or less per litre or per kilogram

Hydrocortisone and hydrocortisone acetate but no other esters of hydrocortisone; for dermal use in medicines containing 1% or less but more than 0.5% by weight of hydrocortisone base with no other active ingredient except an antifungal and in a quantity of 30 grams or less or 30 millilitres or less per container

Macrogols; in oral preparations for bowel cleansing prior to diagnostic, medical or surgical procedures

Nicotine; in lozenges except when sold from a smoking cessation clinic run under the auspices of a registered medical practitioner, nurse, pharmacist or psychologist

Oxiconazole; for vaginal use

Podophyllum; in medicines containing 20% or less; except in medicines containing 1 milligram or less per litre or per kilogram

Strychnine; except in medicines containing 1 milligram or less per litre or per kilogram

Theophylline; in liquid form for oral use in medicines containing 2% or less

Schedule 3

Pharmacy-only Medicines

Atropine; in solid dose form containing 0.3 milligrams or less per dose and 1 milligram or less per recommended daily dose; except in medicines containing 100 micrograms or less per litre or per kilogram; except when used as an antidote in a device designed for self-injection; except when sold by licensees under the Toxic Substances Regulations

Desloratadine

Dibromopropamidine; for ophthalmic use

Etofenamate; for external use

Fluorides; for internal use in medicines containing 2.2 milligrams or less per dose form except in parenteral nutrition replacement preparations; for external use in medicines containing 2.5% or less but more than 0.1% of elemental fluorine

Folic acid; in medicines containing more than 500 micrograms per recommended daily dose except in parenteral nutrition replacement preparations

Formaldehyde; in medicines containing more than 5%

Gelsemium; except in medicines containing 1 milligram or less per litre or per kilogram

Glyceryl trinitrate; except for injection; except in medicines containing 100 micrograms or less per litre or per kilogram

Hydrocortisone and hydrocortisone acetate but no other esters of hydrocortisone; for dermal use in medicines containing 0.5% or less by weight of hydrocortisone base with no other active ingredient except an antifungal and in a quantity of 30 grams or less or 30 millilitres or less per container

Indomethacin; for external use in medicines containing 1% or less; except in medicines containing 1 milligram or less per litre or per kilogram

533

Injectable medicines; except when specified elsewhere in the schedule; except for contrast media or plasma volume expanders

Isopropamide; for dermal use in preparations containing 2% or less

Paraformaldehyde; in medicines containing more than 5%

Potassium; except when specified elsewhere in the schedule; for internal use in slow release or enteric coated forms; in medicines containing more than 100 milligrams per recommended dose except in medicines for oral rehydration therapy, parenteral nutrition replacement or dialysis

Propamidine; for ophthalmic use

Staphisagria; except in medicines containing 0.2% or less

Zinc chloride; for dermal use in medicines containing more than 5%

Medicines for General Sale

Please note that the following medicines are no longer classified as prescription medicines, restricted medicines or pharmacy-only medicines. As such, they are now available for general sale.

Acetomenaphthone
Bentiromide
Bromelains
Broxaldine
Broxyquinoline
Calcium hypochlorite
Calcium salicylate
Camphor, ammoniated
Capsicum oleo-resin
Chromium oxide

Colecalciferol; in medicines for internal use containing 25 micrograms or less per recommended daily dose; in parenteral nutrition replacement preparations

Copper
Cyanocobalamin
Deoxyribonuclease; for external use
Dextranomer
Dextrans
Diamthazole
Dibromopropamidine; except for ophthalmic use
Fluorides; in parenteral nutrition replacement preparations; for external use in medicines containing 0.1% of elemental fluorine

Folic acid; in medicines containing 500 micrograms or less per recommended daily dose; in parenteral nutrition replacement preparations

Formic acid
Hetastarch
Hexamidine
Hippuric acid
Hydrogen peroxide
Hydroiodic acid
Hydroxocobalamin
Ichthammol

Injectable medicines which are contrast media or plasma volume expanders

Iodic acid
Iron; in medicines containing 24 milligrams or less per recommended daily dose; in parenteral nutrition replacement preparations

Irrigation medicines
Isopropyl alcohol
Jaborandi



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2001, No 23


Gazette.govt.nz PDF NZ Gazette 2001, No 23





✨ LLM interpretation of page content

πŸ₯ Classification of Medicines (continued from previous page)

πŸ₯ Health & Social Welfare
21 February 2001
Medicines, Classification, Prescription, Restricted, Pharmacy-only